Search hospitals > Tennessee > Kingsport

Wellmont Holston Valley Hospital and Medical Center

Claim this profile
Kingsport, Tennessee 37660
Global Leader in Cancer
Global Leader in Type 2 Diabetes
Conducts research for Diabetes
Conducts research for Breast Cancer
Conducts research for Adenocarcinoma
121 reported clinical trials
4 medical researchers
Photo of Wellmont Holston Valley Hospital and Medical Center in KingsportPhoto of Wellmont Holston Valley Hospital and Medical Center in KingsportPhoto of Wellmont Holston Valley Hospital and Medical Center in Kingsport

Summary

Wellmont Holston Valley Hospital and Medical Center is a medical facility located in Kingsport, Tennessee. This center is recognized for care of Cancer, Type 2 Diabetes, Diabetes, Breast Cancer, Adenocarcinoma and other specialties. Wellmont Holston Valley Hospital and Medical Center is involved with conducting 121 clinical trials across 281 conditions. There are 4 research doctors associated with this hospital, such as Asheesh Shipstone, Joseph Ley, Morawski, and Emily Morawski, MD.

Area of expertise

1Cancer
Global Leader
Wellmont Holston Valley Hospital and Medical Center has run 42 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Type 2 Diabetes
Global Leader
Wellmont Holston Valley Hospital and Medical Center has run 29 trials for Type 2 Diabetes.

Top PIs

Clinical Trials running at Wellmont Holston Valley Hospital and Medical Center

Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Urothelial Carcinoma
Bladder Cancer
Cancer
Type 2 Diabetes
Ovarian Cancer
Fallopian Tube Cancer
Colorectal Cancer
Image of trial facility.

Support Program

for Breast Cancer

This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Mobile Health

for Breast Cancer

This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Recruiting1 award N/A10 criteria
Image of trial facility.

Questionnaire Choice

for Cancer Data Quality

The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.
Recruiting1 award N/A11 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Wellmont Holston Valley Hospital and Medical Center?
Wellmont Holston Valley Hospital and Medical Center is a medical facility located in Kingsport, Tennessee. This center is recognized for care of Cancer, Type 2 Diabetes, Diabetes, Breast Cancer, Adenocarcinoma and other specialties. Wellmont Holston Valley Hospital and Medical Center is involved with conducting 121 clinical trials across 281 conditions. There are 4 research doctors associated with this hospital, such as Asheesh Shipstone, Joseph Ley, Morawski, and Emily Morawski, MD.